The U.S. Food and Drug Administration (FDA) revised the boxed warning on the label for Metformin hydrochloride on 2026-07-07. This revision provides updated information regarding the risk of lactic acidosis, a serious and potentially fatal adverse event associated with the drug.
Background
Boxed warnings, also known as black box warnings, are the strongest warnings the FDA requires for prescription drugs. They are prominently displayed on drug labels to alert healthcare professionals to serious or life-threatening risks. The presence of such a warning indicates that medical professionals should carefully consider these risks when prescribing the drug, weighing the benefits against the potential for severe adverse events. These warnings are critical for patient safety and guide prescribing practices across various therapeutic areas.
What this means
The revised boxed warning for Metformin hydrochloride specifically addresses the critical risk of lactic acidosis. The FDA's update underscores that postmarketing cases of metformin-associated lactic acidosis have resulted in severe outcomes, including death, hypothermia, hypotension, and resistant bradyarrhythmias. The warning further highlights that the onset of this condition is often subtle, making early detection challenging. This label change is a crucial reminder for clinicians to maintain a high index of suspicion for lactic acidosis, particularly in patients with predisposing factors such as renal impairment, concomitant drug use, or specific medical conditions. For patients and patient advocates, understanding this revised warning is vital for informed discussions with healthcare providers about the risks and benefits of Metformin hydrochloride therapy. Researchers may also find this update relevant for ongoing safety surveillance and studies into the mechanisms and prevention of drug-induced lactic acidosis.
Source
This label revision was issued by the FDA on 2026-07-07. The full details of the updated label, identified by setid 17050df5-9e95-4e1b-ac75-34add289b139, are available on dailymed.nlm.nih.gov.